Ivan Rychlík

发表

Mild cognitive impairment and kidney disease: clinical aspects

G. Spasovski, L. Gesualdo, D. Viggiano, 2020 .

Barriers to early diagnosis of chronic kidney disease and use of sodium-glucose cotransporter-2 inhibitors for renal protection: A comprehensive review and call to action.

T. Tankova, A. Janež, L. Czupryniak, 2024, Diabetes, obesity & metabolism.

Clinical Features, Outcomes, and Response to Corticosteroid Treatment of Acute Tubulointerstitial Nephritis: A Single-Centre Retrospective Cohort Study in the Czech Republic

D. Maixnerova, E. Jančová, R. Ryšavá, 2023, Kidney and Blood Pressure Research.

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

N. Perico, M. Jardine, V. Perkovic, 2023, The Lancet.